LUNG THERAPEUTICS

lung-therapeutics-logo

Lung Therapeutics is a pharmaceutical company targeting niche, orphan drug indications for lung injury and disease, with an emphasis on fibrosis. Current efforts are focused on a severe complication of pneumonia, called loculated pleural effusion, a debilitating condition where fluid has built up in the chest cavity surrounding the lungs and fibrinous scar tissue in the pleural cavity blocks fluid drainage. Their first product, LTI-01 (single chain urokinase plasminogen activator, or scuPA), i... s being studied for safe clearance of fibrinous scar tissue in patients with loculated pleural effusion. By clearing the fibrinous buildup pharmaceutically, the clinical pathway for these patients is significantly improved, enabling simple draining of pleural fluid without surgery. Their longer-term efforts will target improvement of clinical pathways for Acute Lung Injury, Idiopathic Pulmonary Fibrosis and other disease conditions.

#SimilarOrganizations #People #Financial #Event #Website #More

LUNG THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Medical Therapeutics

Founded:
2013-01-01

Address:
Austin, Texas, United States

Country:
United States

Website Url:
http://www.lungtx.com

Total Employee:
11+

Status:
Active

Contact:
737-802-1989

Email Addresses:
[email protected]

Total Funding:
53.91 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Universal Analytics Apache Euro


Similar Organizations

akebia-therapeutics-logo

Akebia Therapeutics

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

interline-therapeutics-logo

Interline Therapeutics

Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.

lucy-therapeutics-logo

Lucy Therapeutics

Lucy Therapeutics is a biotech company providing effective treatments for neurological diseases start with the mitochondria.

odell-family-chiropractic-logo

O'Dell Family Chiropractic

O'Dell Family Chiropractic provide chiropractic treatments tor a range of health conditions.

semma-therapeutics-logo

Semma Therapeutics

Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.


Current Advisors List

robert-mills_image

Robert Mills Board Member @ Lung Therapeutics
Board_member

aaron-fletcher_image

Aaron Fletcher Board Member @ Lung Therapeutics
Board_member
2014-01-01

j-brian-windsor_image

J. Brian Windsor Board Member @ Lung Therapeutics
Board_member

steven-idell_image

Steven Idell Board Member @ Lung Therapeutics
Board_member

Current Employees Featured

charles-garner_image

Charles Garner
Charles Garner Chief Financial Officer @ Lung Therapeutics
Chief Financial Officer

andrew-mazar_image

Andrew Mazar
Andrew Mazar Founder @ Lung Therapeutics
Founder

matt-karpen_image

Matt Karpen
Matt Karpen Director of CMC @ Lung Therapeutics
Director of CMC

steven-idell_image

Steven Idell
Steven Idell Founder & Chief Scientific Officer @ Lung Therapeutics
Founder & Chief Scientific Officer

j-brian-windsor_image

J. Brian Windsor
J. Brian Windsor Chief Executive Officer @ Lung Therapeutics
Chief Executive Officer
2013-07-01

sharon-morriss_image

Sharon Morriss
Sharon Morriss SVP, Clinical Development @ Lung Therapeutics
SVP, Clinical Development
2021-06-01

Founder


andrew-mazar_image

Andrew Mazar

steven-idell_image

Steven Idell

Investors List

bios-partners_image

Bios Partners

Bios Partners investment in Series C - Lung Therapeutics

bios-partners_image

Bios Partners

Bios Partners investment in Series B - Lung Therapeutics

ut-horizon-fund_image

UT Horizon Fund

UT Horizon Fund investment in Series B - Lung Therapeutics

ut-horizon-fund_image

UT Horizon Fund

UT Horizon Fund investment in Series A - Lung Therapeutics

texas-venture-labs_image

Texas Venture Labs

Texas Venture Labs investment in Non Equity Assistance - Lung Therapeutics

ut-horizon-fund_image

UT Horizon Fund

UT Horizon Fund investment in Convertible Note - Lung Therapeutics

Official Site Inspections

http://www.lungtx.com Semrush global rank: 5.07 M Semrush visits lastest month: 1.63 K

  • Host name: ec2-174-129-30-187.compute-1.amazonaws.com
  • IP address: 174.129.30.187
  • Location: Ashburn United States
  • Latitude: 39.0481
  • Longitude: -77.4728
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20149

Loading ...

More informations about "Lung Therapeutics"

Lung Therapeutics - Crunchbase Company Profile

Organization. Lung Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ...See details»

Rein Therapeutics

Jan 10, 2025 Pioneering multi-pathway therapies that work at both an anti-fibrotic and regenerative levelSee details»

Lung Therapeutics Company Profile | Management and Employees …

Www.lungtx.com Lung Therapeutics Profile and History Headquartered in Austin, Texas, Lung Therapeutics, Inc. is a clinical stage biopharmaceutical company formed to leverage leading …See details»

Lung Therapeutics - Overview, News & Similar companies

Jul 13, 2021 Lung Therapeutics contact info: Phone number: (737) 802-1979 Website: www.lungtx.com What does Lung Therapeutics do? Headquartered in Austin, Texas, Lung …See details»

Lung Therapeutics 2025 Company Profile: Valuation, …

Lung Therapeutics General Information Description. Developer of novel peptide drugs intended to facilitate treatments for fibrosis and lung conditions. The …See details»

Lung Therapeutics, Inc. | Austin TX - Facebook

Lung Therapeutics, Inc., Austin, Texas. 842 likes · 6 talking about this. Lung Therapeutics, Inc. is a pharmaceutical company targeting niche, orphan drug indications for lunSee details»

Lung Therapeutics (USA) Funding: $53.9M - medicalstartups.org

6 days ago Lung Therapeutics pursues innovative treatments for underserved, life-threatening lung conditions. Our therapies for Idiopathic Pulmonary Fibrosis and Loculated Pleural …See details»

Lung Therapeutics Company Profile -Sales, Contacts, Competitors …

Www.lungtx.com: There are 16 Companies located at 3801 S CAPITAL OF TEXAS HWY, Austin, TX 78704 ... This organization has been operating for approximately 2 years. Lung …See details»

Lung Therapeutics, Inc. Overview | SignalHire Company Profile

Contact Email: [email protected]: Phone Number: 737.802.1989: Lung Therapeutics, Inc. industries Biotech, Biotechnology, PharmaceuticalsSee details»

Lung Therapeutics, Inc. - Employees, Contact info, Overview - Wiza

May 1, 2024 View info about Lung Therapeutics, Inc. (lungtx.com). Lung Therapeutics, Inc. is a company located in Austin, TX, United States. Find employees, official website ...See details»

Lung Therapeutics, Inc. Online Press Kit - About Us

[email protected]. Company Contact. Brian Windsor, PhD Chief Executive Officer Lung Therapeutics, Inc. 737-802-1979 bwindsor@lungtxcom. PR Agency Contact. Sandra Oak …See details»

Lung Therapeutics CEO and Key Executive Team | Craft.co

Lung Therapeutics's Chief Executive Officer, Director is Brian Windsor. Other executives include Charles Garner, Chief Financial Officer; William C. Fairey, Director and 7 others. See the full …See details»

Lung Therapeutics - Craft

Lung Therapeutics is a biopharmaceutical company developing medicines for unmet medical needs in fibrosis and lung disease. Its two lead drug candidates are LTI-01, a pro-enzyme for …See details»

Lung Therapeutics: Employee Directory | ZoomInfo.com

Lung Therapeutics Contact Info: Phone number: (737) 802-1979 Website: www.lungtx.com What does Lung Therapeutics do? Headquartered in Austin, Texas, Lung Therapeutics, Inc. is a …See details»

Lung Therapeutics - Golden

Lung Therapeutics is a therapeutics for lung injury and disease company founded in 2013 by Andrew Mazar, Steven Idell and Sreerama Shetty.See details»

Austin Texas based Lung Therapeutics is raising ... - intelligence360

Apr 27, 2022 Austin, TX - According to filings with the U.S. Securities and Exchange Commission, Lung Therapeutics is raising $15,000,000.00 in new funding. Sources indicate as …See details»

Lung Therapeutics, Inc. Raises $36 Million in Series C Financing

Jun 4, 2019 Release Summary. Austin-based clinical stage biopharmaceutical company Lung Therapeutics, Inc. completes $36 million Series C that will fund ongoing clinical trials.See details»

Lung Therapeutics Announces Successful Completion of

Mar 22, 2022 Company Contact: Charles T. Garner Chief Financial Officer Lung Therapeutics, Inc. 737-802-1979 [email protected]. Release Summary.See details»

Pharma Start-up Lung Therapeutics, Inc. Achieves ... - Business Wire

Oct 28, 2014 AUSTIN, Texas--(BUSINESS WIRE)--Lung Therapeutics, Inc., a pharmaceutical company focused on niche, orphan drug indications in lung injury and disease, has closed on …See details»

Lung Therapeutics, Inc. Doses First Patient in Phase 1 Clinical Trial ...

AUSTIN, Texas, March 14, 2017 /PRNewswire/ -- Lung Therapeutics, Inc., a clinical stage pharmaceutical company focused on niche, orphan drug indications in lung injury and disease, …See details»

linkstock.net © 2022. All rights reserved